BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 2221729)

  • 1. [Value of the administration of trimetazidine associated with hemodilution in the treatment of sudden deafness. Report of a multicenter study].
    Beutter P; Guinard F; Jalbert D; Marsac A; Morin R; Sauvage JP; Soudant J
    Ann Otolaryngol Chir Cervicofac; 1990; 107(5):345-50. PubMed ID: 2221729
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Trimetazidine and degenerative deafness. Effect on hearing and integration].
    Haguenauer JP; Bebear JP; Bordes LR; Jacquot M; Mercier J; Morgon A; Pech A; Romanet P; Thomassin JM; Wayoff M
    Ann Otolaryngol Chir Cervicofac; 1990; 107 Suppl 1():51-6. PubMed ID: 2240999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Value of the association of normovolemic dilution and hyperbaric oxygenation in the treatment of sudden deafness. A retrospective study].
    Zennaro O; Dauman R; Poisot A; Esteben D; Duclose JY; Bertrand B; Cros AM; Milacic M; Bebear JP
    Ann Otolaryngol Chir Cervicofac; 1993; 110(3):162-9. PubMed ID: 8239337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The efficacy of trimetazidine in cochleovestibular disorders of ischemic origin. A crossover control versus placebo trial].
    Coyas A
    Ann Otolaryngol Chir Cervicofac; 1990; 107 Suppl 1():82-7. PubMed ID: 2241007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Treatment of sudden deafness apropos of 447 cases].
    Cura O; Karci B; Uluöz U; Kirazli T; Ogüt F; Bilgen V
    Rev Laryngol Otol Rhinol (Bord); 1993; 114(2):121-4. PubMed ID: 8284553
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [(Treatment of sudden deafness: first results of a comparative study)].
    Dauman R; Cros AM; Poisot D
    J Otolaryngol; 1985 Feb; 14(1):49-56. PubMed ID: 4068091
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Normovolemic hemodilution in the treatment of sudden deafness].
    Heitzmann P; Robier A; Angelina A; Capelier Y; Hassani Y; Beutter P
    Ann Otolaryngol Chir Cervicofac; 1990; 107(8):521-5. PubMed ID: 2085253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Trimetazidine versus betahistine in Ménière's disease. A double blind method].
    Martini A; De Domenico F
    Ann Otolaryngol Chir Cervicofac; 1990; 107 Suppl 1():20-7. PubMed ID: 2240995
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A multicenter double blind versus placebos study of trimetazidine in tinnitus. A clinical approach to tinnitus].
    Pech A
    Ann Otolaryngol Chir Cervicofac; 1990; 107 Suppl 1():66-7. PubMed ID: 2241001
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hemodilution therapy with hydroxyethyl starch solution (130/0.4) in unilateral idiopathic sudden sensorineural hearing loss: a dose-finding, double-blind, placebo-controlled, international multicenter trial with 210 patients.
    Klemm E; Bepperling F; Burschka MA; Mösges R;
    Otol Neurotol; 2007 Feb; 28(2):157-70. PubMed ID: 17255882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Evaluation of the therapeutic efficacy of vastarel 20 mg (trimetazidine) in cochleovestibular syndromes. A double-blind study versus placebo].
    Wayoff M
    Ann Otolaryngol Chir Cervicofac; 1984; 101(7):565-9. PubMed ID: 6391338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized, double blind, placebo controlled trial on the safety and efficacy of continuous intratympanic dexamethasone delivered via a round window catheter for severe to profound sudden idiopathic sensorineural hearing loss after failure of systemic therapy.
    Plontke SK; Löwenheim H; Mertens J; Engel C; Meisner C; Weidner A; Zimmermann R; Preyer S; Koitschev A; Zenner HP
    Laryngoscope; 2009 Feb; 119(2):359-69. PubMed ID: 19172627
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Trimetazidine versus betahistine in vestibular vertigo. A double blind study].
    Kluyskens P; Lambert P; D'Hooge D
    Ann Otolaryngol Chir Cervicofac; 1990; 107 Suppl 1():11-9. PubMed ID: 2240994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The effects of trimetazidine on ergometric parameters in exercise-induced angina. Controlled multicenter double blind versus placebo study].
    Sellier P
    Arch Mal Coeur Vaiss; 1986 Aug; 79(9):1331-6. PubMed ID: 3101636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sudden deafness in vertebrobasilar ischemia: clinical features, vascular topographical patterns and long-term outcome.
    Lee H; Baloh RW
    J Neurol Sci; 2005 Jan; 228(1):99-104. PubMed ID: 15607217
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic model for predicting hearing recovery in idiopathic sudden sensorineural hearing loss.
    Cvorović L; Deric D; Probst R; Hegemann S
    Otol Neurotol; 2008 Jun; 29(4):464-9. PubMed ID: 18434930
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intratympanic dexamethasone for sudden sensorineural hearing loss after failure of systemic therapy.
    Haynes DS; O'Malley M; Cohen S; Watford K; Labadie RF
    Laryngoscope; 2007 Jan; 117(1):3-15. PubMed ID: 17202923
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Value of the combination of trimetazidine (Vastarel 20 mg) with diltiazem (Tildiem 60 mg) in stable effort angina. A double-blind versus placebo multicenter study].
    Lévy S
    Ann Cardiol Angeiol (Paris); 1995 Apr; 44(4):203-12. PubMed ID: 7632029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Sudden deafness and its therapy. Clinical study of 548 cases].
    Michels E; Matzker J
    Laryngol Rhinol Otol (Stuttg); 1988 Apr; 67(4):171-6. PubMed ID: 3386368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The emergency in the management of sudden hearing loss; still of present interest? A study of 109 cases of sudden deafness].
    Ayache S; Tramier B; Michel L; Strunski V
    Rev Laryngol Otol Rhinol (Bord); 2008; 129(4-5):259-62. PubMed ID: 19408506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.